Literature DB >> 9885205

Deletion of a critical internalization domain in the G-CSFR in acute myelogenous leukemia preceded by severe congenital neutropenia.

M G Hunter1, B R Avalos.   

Abstract

Acquired mutations in the granulocyte colony-stimulating factor receptor (G-CSFR) occur in a subset of patients with severe congenital neutropenia (SCN) who develop acute myelogenous leukemia (AML). These mutations affect one allele and result in hyperproliferative responses to G-CSF, presumably through a dominant-negative mechanism. Here we show that a critical domain in the G-CSFR that mediates ligand internalization is deleted in mutant G-CSFR forms from patients with SCN/AML. Deletion of this domain results in impaired ligand internalization, defective receptor downmodulation, and enhanced growth signaling. These results explain the molecular basis for G-CSFR mutations in the pathogenesis of the dominant-negative phenotype and hypersensitivity to G-CSF in SCN/AML.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9885205

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

1.  Mutations in the transmembrane and juxtamembrane domains enhance IL27R transforming activity.

Authors:  Que T Lambert; Anuradha Pradhan; J Devon Roll; Gary W Reuther
Journal:  Biochem J       Date:  2011-08-15       Impact factor: 3.857

Review 2.  Neutrophil disorders and their management.

Authors:  R Lakshman; A Finn
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

Review 3.  Biology and significance of the JAK/STAT signalling pathways.

Authors:  Hiu Kiu; Sandra E Nicholson
Journal:  Growth Factors       Date:  2012-02-20       Impact factor: 2.511

4.  Alternatively spliced, truncated GCSF receptor promotes leukemogenic properties and sensitivity to JAK inhibition.

Authors:  H M Mehta; M Futami; T Glaubach; D W Lee; J R Andolina; Q Yang; Z Whichard; M Quinn; H F Lu; W M Kao; B Przychodzen; C A Sarkar; A Minella; J P Maciejewski; S J Corey
Journal:  Leukemia       Date:  2013-10-30       Impact factor: 11.528

Review 5.  Maximizing Breast Cancer Therapy with Awareness of Potential Treatment-Related Blood Disorders.

Authors:  Henry G Kaplan; Gregory S Calip; Judith A Malmgren
Journal:  Oncologist       Date:  2020-02-19

Review 6.  Mechanisms of leukemic transformation in congenital neutropenia.

Authors:  Daniel C Link
Journal:  Curr Opin Hematol       Date:  2019-01       Impact factor: 3.284

7.  A t(1;9) translocation involving CSF3R as a novel mechanism in unclassifiable chronic myeloproliferative neoplasm.

Authors:  Jesús Gutiérrez-Abril; Iñigo Santamaría; Ana S Pitiot; Ana Gutiérrez-Fernández; Ángel Alvarez-Eguiluz; José M Vicente; Carmen Sanzo; Soledad González-Muñiz; Milagros Balbín; Xose S Puente
Journal:  Haematologica       Date:  2017-09-21       Impact factor: 9.941

8.  Neutrophil elastase downmodulates native G-CSFR expression and granulocyte-macrophage colony formation.

Authors:  Melissa G Piper; Pam R Massullo; Megan Loveland; Lawrence J Druhan; Tamila L Kindwall-Keller; Jing Ai; Alexander Copelan; Belinda R Avalos
Journal:  J Inflamm (Lond)       Date:  2010-01-21       Impact factor: 4.981

9.  Ubiquitination and degradation of the thrombopoietin receptor c-Mpl.

Authors:  Sebastian J Saur; Veena Sangkhae; Amy E Geddis; Kenneth Kaushansky; Ian S Hitchcock
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

Review 10.  G-CSF and GM-CSF in Neutropenia.

Authors:  Hrishikesh M Mehta; Michael Malandra; Seth J Corey
Journal:  J Immunol       Date:  2015-08-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.